Helicobacter pylori is the cause of chronic gastritis and is involved in the pathogenesis of peptic ulceration, primary gastric lymphoma, and gastric adenocarcinoma. [1] [2] [3] The development of clinically significant disease appears however to depend on a number of factors, including the virulence of the infecting strain, susceptibility of the host, and environmental cofactors. 4 The majority of vacuolating cytotoxin (VacA) producing isolates 5 6 possess the gene cagA, a marker for the cag pathogenicity island (cagPAI), and production of the CagA protein is associated with clinically significant gastroduodenal disease. [7] [8] [9] [10] cag + strains encode a type IV bacterial secretion system which mediates translocation of CagA into host cells where it is phosphorylated and activates a number of intracellular pathways to induce cytoskeletal changes. [11] [12] [13] [14] Disruption of many cagPAI genes in cag + strains abolishes these eVects. The presence of the cagPAI appears to be associated with duodenal ulceration in European and Asian populations 15 16 but patients with peptic ulcer disease sometimes harbour H pylori strains with partial or complete deletions of the cagPAI 15 and a significant number (53-82%) of isolates from patients without ulcers have intact cagPAIs. [15] [16] [17] Little is known about the structure of the cagPAI in patients with gastric adenocarcinoma or its structure in African populations.
South African H pylori isolates from Cape Town are characterised by the universal presence of cagA 18 but there is no information on the structure of the cagPAI. However, South African isolates have diVerences in vacA, the gene encoding the vacuolating cytotoxin. 18 19 In the current study, we investigated the presence and structural organisation of key regions of the cagPAI. The regions targeted and tested using specific polymerase chain reaction (PCR) assays are the functionally important cagA, cagE, and cagM genes in the cagI region, 20 21 and three cagII marker genes, cagT and cag6-7 21 ( fig 1) . Strains which were PCR Abbreviations used in this paper: PAI, pathogenicity island; PCR, polymerase chain reaction.
Figure 1 Schematic diagram of the cag pathogenicity island with the putative junction site between cagQ∼S where IS605 may be located (vertical arrow, x) noted in NCTC11638.
Genes and positions are from GenBank accession number AC000108 (cagII) and U60176 (cagI). Polymerase chain reaction amplimers analysed in this study are denoted by bold horizontal lines beneath the genes. negative for these cagII marker genes were analysed for the entire cag5-10 region (which includes the virD4 homologue, cag10) as well as for the downstream gene cag13. In addition, whether the cagI and cagII portions of the PAI were contiguous was tested by PCR amplifying their putative junction using primers derived from each side. We hypothesised that H pylori isolates from diVerent clinical diseases would exhibit variability in their cagPAI and that there would be an association between the type of cagPAI and type of vacA allele.
Materials and methods

H PYLORI STRAINS AND DNA
A total of 109 H pylori isolates were examined from 86 patients. Demographic data and endoscopic and histological diagnoses were recorded for all patients (table 1) . Sixty seven (78%) patients had a single strain isolated. Nineteen (22%) patients had two or three nonidentical isolates, as assessed by diVerent random amplified polymorphic DNA (RAPD) PCR fingerprint patterns. Fifty six of the strains had previously had their vacA types determined in an earlier study. 18 Reference strains 26695 isolated from a patient in the UK with gastritis 22 and J99 isolated from a US patient with duodenal ulcer disease 23 were used as positive controls.
PCR AMPLIFICATION AND DETECTION OF AMPLIFIED DNA PRODUCTS
Oligonucleotide primers used for PCR are listed in table 2. Two sets of primers were used for each gene examined. PCR amplification was performed as previously described. 18 24 Following initial denaturation at 94°C for one minute, each reaction consisted of 35 cycles of denaturation at 94°C for one minute, annealing and extension at an appropriate temperature for 2-4 minutes, and final extension at 72°C for 10 minutes. Annealing temperatures were set at 50°C for cag2/4 and picBF/R; 53°C for cag5/6, cag7/12, cag8/9, cag10/11, cag13/14, cag13F/R, cagTF/R, cagTF2/QR, LECF/cag10R, and cagEF/R; and 55°C for F1/B1, cagMF/R, and cag67F/R. 15 16 25 26 Each PCR mixture (20 µl) was subjected to gel electrophoresis on 1% agarose gels and either a 100 bp or 0.12-23.1 kbp DNA ladder (Roche Diagnostics, Johannesburg, South Africa) was used as a size marker. Long distance PCR was performed with the Expand PCR System (Roche Diagnostics), as recommended by the supplier. 27 
NUCLEOTIDE SEQUENCING
The 3' region of cagA, which adequately discriminates between "Asian" and "nonAsian" strains, 28 was sequenced in 12 South African isolates (two Black, seven Cape coloured, three White). PCR products (primer set cag2/4) 25 were gel extracted (Qiaex II gel extraction kit; Qiagen, Cape Town, South Africa) and sequenced on an ABI Prism 377 automated sequencer (ABI, Foster City, California, USA) using the ABI Prism BigDye terminator cycle sequencing reagent kit with AmpliTaq DNA polymerase FS (PE Biosystems, Johannesburg, South Africa), as 5' AGCTAGGGAAAAATCTGTCTATGCC 5648 †HP numbers from Helicobacter pylori strain 26695 (GenBank accession number AE000511). */+Location, position on H pylori (GenBank accession number U60176 or AC000108). described previously. 29 PCR and direct sequencing were performed at least twice to determine DNA sequences for each strain.
COMPUTER ANALYSIS DNA and protein sequences were analysed using the National Center for Biotechnology Information (NCBI) server (USA), and Internet based searches were preformed at NCBI, the Institute for Genome Research (TIGR, Maryland, USA) and Astra-Zeneca (Boston, USA).
STATISTICAL METHODS
Data (n=109) were analysed using the 2 test or Fisher's exact test, as appropriate. Probability levels <0.05 were considered statistically significant.
Results
CLINICAL PROFILES
All samples from patients with clinically significant disease (peptic ulcer disease, gastric adenocarcinoma) were obtained as part of the clinical protocols. Use of non-steroidal antiinflammatory drugs was an exclusion criterion in all contributing studies. All 30 patients with peptic ulcer disease had active duodenal ulceration at the time of endoscopy. Of the 19 patients with gastric adenocarcinoma, 10 had carcinoma in the antrum, two in the antrum and body, and two in the body alone. In five cases the primary site could not be determined. Tumours were classed histologically as mixed in two cases, poorly diVerentiated in three, and unknown in six, while four were intestinal and four were diVuse. Patients with no clinically significant upper gastrointestinal disease (gastritis alone) were drawn from two populations.
Twenty six (70%) were asymptomatic volunteers receiving no prescribed medication for dyspepsia and 11 were derived from a group of non-ulcer dyspeptics, known not to be receiving potent acid suppressive therapy. Of the 37 patients with gastritis alone, 29 had histological biopsies from the antrum and corpus, allowing for classification of their pattern of gastritis. Of these, 19 (66%) had pangastritis and four (14%) had antral predominant gastritis. Intestinal metaplasia was present in five patients. None of these patients had significant gastroduodenal pathology.
cagA SEQUENCING Analysis of cagA in 12 South African isolates demonstrated no significantly greater diVerences in homology between isolates from diVerent ethnic groups (83-94% identity) than between isolates from the same ethnic group. cagA in all strains demonstrated significantly closer homology with cagA from the European strains (HP0547 and JHP495; 73-94% identity) than with cagA from the Japanese strains JK25 (GenBank accession number AF043487; 52-57% identity), JK253 (GenBank accession number AF043489; 33-44%), and JK271 (GenBank accession number AF043488; 38-43%). These results confirm that South African cagA in this study was "non-Asian" in origin and strongly suggests that these cag + strains share more sequence identity with European 15 17 than with Japanese strains.
PCR ANALYSIS OF THE cagI REGION
H pylori isolates were analysed with two diVerent primer sets for the cagA (HP547), cagE (HP544), and cagM (HP537) genes of the cagI region. Agreement between primer sets for cagA was 97%, cagE 100%, and cagM 98%.
Isolates were considered positive for a gene if one primer set gave successful PCR amplification. The reference strains 26695 and J99 were positive for each primer combination used. Overall, 88 (81%) of 109 strains had all the cagI marker genes. All 109 of the strains were cagA + using primers F1/B1 and cag2/4 ( fig 2) . The gene cagE was present in significantly more strains isolated from patients with peptic ulceration (34 of 36 (94%); p<0.009) and gastric adenocarcinoma (24 of 26 (92%); p<0.04) than strains isolated from patients with gastritis alone (34 of 47 (72%)). The gene cagM was present in 85% of isolates from patients with gastritis alone, 94% of peptic ulcer disease isolates, and 96% of gastric adenocarcinoma isolates (NS). There were no statistically significant diVerences in the presence of cagE or cagM either between ethnic groups or between gastritis alone patients with or without intestinal metaplasia (data not shown). These results demonstrate that functionally important elements of the cagI region (cagAcagM) were present in the majority of strains, irrespective of disease status. However, cagE (which has previously been shown to be essential for CagA translocation and phosphorylation 14 ) was absent in 25% of isolates (from all ethnic groups) from patients with no clinically significant disease. To exclude sequence heterogeneity at primer annealing sites in the 5' region of the cagPAI as a reason for the negative PCR results, 40 isolates which were PCR negative for cag6-7 were also examined for cag5-10 (HP519-524). This region includes cag10, a virD4 homologue and putative toxin, and should result in a PCR product of 3370 bp (predicted from GenBank accession number AC000108). Fourteen (35%) of 40 isolates gave no PCR product, and these are further examined below. The other 26 (65%) of cag6-7 − isolates gave PCR amplimers ranging in size from 880 to 2902 bp compared with the expected 3370 bp obtained in all 10 cag6-7 + isolates (and in the two reference strains) tested, confirming deletions in the cagII region. To define if the deleted cagII region extended beyond cag10, we next tested whether an additional cagII marker gene, cag13 (HP527), which is between cag10 and cagT, was present in these 26 isolates. Twenty five (96%) of these 26 isolates were cag13 + (as were all 10 cag6-7 + isolates tested as positive controls, and the two reference strains). Long PCR using primers to examine the entire cagII region (cag5-cagT) was performed on the one isolate negative for cag13. This should result in a PCR product of 18 402 bp (predicted from GenBank accession number AC000108). A product of 8396 bp was amplified. These results suggest that 26 isolates, which were all PCR negative (using two diVerent primer sets) for cagT, contain a partial cagII.
Figure 2 Schematic diagram of cagI with the polymerase chain reaction amplimers of the three genes analysed (top). Genes and positions are from GenBank accession number U60176. Prevalence of target genes in the diVerent
Thereafter we investigated 14 isolates which appeared to have lost the 5' region of cagII (PCR negative for both cag6-7 and cag5-10) using long PCR to examine the entire cagII region (cag5-cagT). PCR amplicons of 280-3105 bp (compared with a product of 18 402 bp predicted from GenBank accession number AC000108) were generated in 10 of the 14 isolates. These results suggest that these isolates had lost the majority of the cagII region. Analysis of the remaining four isolates which gave no PCR amplimers with these primers demonstrated that one isolate had lost all the genes tested to the left of cagM; one isolate, all genes tested to the left of cagE, and two isolates only contained cagA.
Finally, we related these results to clinical status. This showed that a complete intact cagII region (cag6-cagT) was present in significantly more isolates from patients with peptic ulcer disease (81%) than in patients with gastritis alone (38%; p=0.0001). There were no diVerences in the distribution of this marker in gastritis alone patients with dyspepsia (36%) or without symptoms (46%). Interestingly, however, the five gastritis alone patients with intestinal metaplasia also had an intact cagPAI. Seventy three per cent of isolates from patients with gastric adenocarcinoma had a complete intact cagII (p=0.004 v gastritis alone). Some elements of the cagII region (cag10-cagT) were present in all gastric adenocarcinoma isolates whereas 11 isolates from patients with gastritis alone lacked the entire cagII region (p<0.006 v gastritis alone). Further analysis demonstrated no significant relationship between diVerent ethnic populations and the presence of an intact cagII region ( 2 =8.08, p=0.09).
ASSESSMENT OF CONTIGUITY OF cagI AND cagII
REGIONS
The primer combinations of cag7/12 and cagTF/QR test for the presence of the cagQ∼S/T genes (HP535-532) and also for joined cagI and cagII regions. Agreement between primer sets for cagQ∼S/T was 78%. This is lower than for cagI but reflects the fact that these primer combinations identify diVerent 5' genes. PCR amplification using these primer sets resulted in the expected amplicon sizes in both 26695 and J99. Seventy five (85%) isolates with all the marker genes for the cagI region were cagQ∼S/T + . Significantly more cagI isolates from patients with peptic ulceration (31 of 34 (91%); p<0.02) and gastric adenocarcinoma (23 of 23 (100%); p<0.002) were cagQ∼S/T + compared with isolates from patients with gastritis alone (21 of 31 (68%)). Sixty five (98%) of 66 isolates with all the marker genes for the cagII region were cagQ∼S/ T + . Overall, sixty five (60%) isolates all had markers for cagI, cagII, and a contiguous pathogenicity island; 77% of isolates from patients with peptic ulcer disease (p<0.001) and 73% of isolates from patients with gastric adenocarcinoma (p<0.01) compared with only 18 (40%) isolates from patients with gastritis alone.
Figure 3 Schematic diagram of cagII with the polymerase chain reaction amplimers of the three genes analysed (top). Genes and positions are from GenBank accession number AC000108. Prevalence of target genes in the diVerent
Twenty eight isolates did not have an amplifiable cagQ∼S/T product. One of the isolates was also cagT, cag13, and cag6-7 PCR positive. This suggests that this isolate (from a patient with peptic ulcer disease) had a complete but spatially separated pathogenicity island. Sixteen of the remaining 27 cagQ∼S/T -isolates (59%) had deletions in the cagI region while 26 (96%) had deletions in the cagII region. These results suggest that the presence of a cagQ∼S/T amplimer may be an alternate marker for the cagII region.
PREVALENCE OF THE IS605 INSERTION SEQUENCE
While 26695 had an intact IS605 sequence (tnpA+tnpB) detected by PCR and J99 only exhibited tnpA, only three (3%) South African isolates were PCR positive for IS605. All three had all the marker genes for cagPAI and yielded PCR products with the cag7/12 and cagTF/QR primer sets, suggesting that the complete insertion sequence was elsewhere in the genome. Analysis of the cagPAI deletion end points in the 28 isolates which did not have an amplifiable cagQ∼S/T gene product demonstrated that IS605 (tnpA) was present in six (27%), suggesting that this insertion sequence may play a role in cagPAI disruption in a proportion of isolates.
RELATIONSHIP BETWEEN GENE MARKERS AND vacA
STATUS
As previously demonstrated, 18 19 vacA s1 occurred significantly more often in isolates from patients with peptic ulceration (p<10 −5 ) or gastric adenocarcinoma (p<2×10 −4 ) while vacA s2 invariably occurred in patients with gastritis alone. In addition, the vacA m1 mid region type was present more often in patients with clinically significant disease (p<0.01).
When analysing the data by vacA status (table 3) , there was a significant diVerence in the distribution of vacA allele types between the diVerent cagPAI groups ( 2 =52.76; p<10 −5 ). A strong association was noted between vacA s1m1 and strains containing the complete cagPAI. Fifty two (78%) of 66 vacA s1m1 strains had all the genetic markers (cag6-cagA) compared with two of 18 (12%; p<10 −5 ) vacA s2m2 strains. Sixteen of 18 vacA s2m2 strains (88%) had partial deletions of the cagPAI (p<0.0001 v vacA s1m1; p<0.005 v vacA s1m2).
There was also a strong association between specific vacA alleles and absence of contiguous cagPAI. Significantly more vacA s2 isolates (13 of 20 (65%)) were cagQ∼S/T PCR negative compared with 14 of 83 (17%; p<0.0001) vacA s1 strains, suggesting that the vacA s2 allele may be a associated with loss of this region.
Discussion
Our results indicate that the cag PAI, using a subset of previously defined functionally important marker genes, appears to be complete and contiguous (cag6-cagA) in 60% of South African H pylori isolates. However, more than one third of isolates had non-amplifiable gene regions in the island, despite possessing cagA. The caveat of over interpretation of PCR results is recognised, as this methodology can fail for a number of reasons, including unexpected sequence divergence at primer annealing sites. Such heterogeneity could conceivably explain our findings although our interpretation of deletion of cag regions is much more likely for several reasons. Firstly, we took care to use two established diVerent primer sets per gene site to confirm negative forms. Secondly, these primer combinations have previously been used to identify cag genes in European populations, 15 17 and South African H pylori cag + isolates share more sequence homology with European than "Asian" strains (this study and Achtman and colleagues 30 ). Thirdly, "missing" gene markers were almost invariably adjacent which could readily be explained by missing regions of cag but not by diVerences in primer annealing.
The insertion sequence IS605 replaced the deleted regions of the cagQT in 25% of strains with deletions. This supports the hypothesis that this DNA element may generate rearrangements and deletions in a small proportion of South African strains to result in subpopulations of organisms with diVerences in virulence. 20 21 How deletions occur in other strains is unclear. Irrespective of the mode of genetic deletion, strains that carry the cagA gene but have internal deletions in the cagPAI should probably be classified as functionally cag − rather than cag + . This is evidenced by the fact that such strains are often not associated with disease (current study) and that many different artificial mutants in cag genes reduce the cagPAI, vacA, and gastroduodenal diseaseability of cag + strains to induce IL-8 secretion from epithelial cells. 20 While the majority of isolates (∼80%) from patients with peptic ulceration had all the marker genes for a complete cagPAI, less than half (∼40%) of isolates from patients with gastritis alone had this pathogenic fingerprint. All (100%) tested strains, irrespective of the organisation of the PAI, were cagA + . Data on the cagPAI from the rest of Africa are scarce but CagA appears to be commonly expressed. 31 Our data suggest dissociation between the presence of cagA and other genes in the cagPAI island and further that analysis of the PAI may be a prerequisite for investigation of relationships with gastroduodenal disease processes. The presence of an intact cagPAI in the majority of South African peptic ulcer disease isolates supports a role for the genes in this island in the pathogenesis of this disease.
Analysis of the distribution of the virulence associated vacA alleles demonstrated that subtype s1/m1 was strongly associated with a complete island while subtype s2/m2 was associated with deletions in cagII. These findings suggest a functional association between an active s1/m1 vacuolating cytotoxin and an intact cag pathogenicity island. This is supported by the observation of a significantly negative relationship between the virulence associated vacA s1 allele and deletions in cagII.
The association between genes in the cagPAI other than cagA and gastric adenocarcinoma has not previously been reported. Our results demonstrate significant diVerences between isolates from patients with gastritis alone and those with this disease. Specifically, an intact frequently contiguous PAI was found more often in patients with cancer than in patients without clinically significant disease. The high prevalence of this marker made subanalysis of the gastric cancer types inappropriate. Interestingly, an intact cagPAI was found more often in gastritis alone patients who had intestinal metaplasia. Intestinal metaplasia is known to be a risk factor for gastric adenocarcinoma.
The finding of a conserved pathogenicity element (cagPAI) shared by isolates from patients with gastric adenocarcinoma and peptic ulcer disease is of interest given the inverse relationship between these two diseases. That strains with an intact cagPAI are present in the older gastric cancer group and the younger peptic ulcer group suggests that the presence of an intact PAI in infecting strains is not due to an age cohort eVect. It also suggests that an intact PAI, while being a marker for more severe mucosal damage, may not be a specific marker for either of these diseases. This is entirely compatible with the current understanding of the multifactorial nature of their pathogenesis where the distribution of gastric mucosal damage may be determined by factors such as host genetics and the environment. 4 An alternative or additional hypothesis however is that other bacterial elements may be important. For example, it is possible that while an intact PAI (type IV secretion system) is necessary to deliver CagA into epithelial cells it is the structure of CagA which determines which intracellular pathway (secretory or proliferative) a cell undergoes. 32 The presence of a contiguous cagPAI in 60% of patients suggests that it is conserved in most South Africans as it is in most European and almost all Asian populations. [15] [16] [17] The importance of genes in this island (particularly in cagII) to the pathogenesis of gastroduodenal disease in South Africa is however suggested by the prevalence of deletions in the 5' region in patients with gastritis alone. In addition, the strong relationship between the virulent vacA type s1/m1 and the entire PAI would seem to support the importance of both of these elements to disease pathogenesis although it appears that the relationship with clinically significant disease is stronger for vacA alleles than for an intact cagPAI. The finding of similar pathogenic elements from strains isolated from patients with either peptic ulcer disease or gastric adenocarcinoma however indicates that further work is required to diVerentiate the relationship between specific genes, host factors, and disease processes.
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